相关实验视频
Updated: Sep 8, 2025

08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
8.0K
对BAK和BAX的强效和选择性结合剂的计算设计
Stephanie Berger1,2,3, Erinna F Lee4,5,6, Tiffany J Harris5
1Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Science advances
|September 5, 2025
概括
研究人员设计了强大的蛋白质结合剂, 这些结合剂可以根据度触发或抑制细胞死亡,从而提供新的治疗策略.
科学领域:
- 分子生物学
- 蛋白质工程
- 生物化学
背景情况:
- 预的蛋白质BAK和BAX是编程细胞死亡的关键调节者.
- 开发BAK和BAX的强效和选择性调节剂是一个重大挑战.
- 了解BAK和BAX激活的精确机制对于治疗干预至关重要.
研究的目的:
- 通过计算来设计BAK和BAX的高亲和性选择性蛋白质结合剂.
- 研究这些设计的结合剂调节BAK和BAX活性的机制.
- 确定这些结合剂对亡的最佳度依赖作用.
主要方法:
- 使用计算式蛋白质设计生成新型结合剂.
- 对BAK和BAX进行了结合性和特异性的评估.
- 进行了功能性测试,以评估结合剂对孔隙形成和膜透的影响.
- 使用X射线结晶学来阐明结合剂与蛋白质相互作用的结构基础.
主要成果:
- 对BAK和BAX具有100倍以上特异性的高亲和结合剂成功设计.
- 低度的结合剂激活了BAK/BAX,诱导了孔隙形成和亡.
- 过多的粘合剂度抑制了膜透.
- 结晶学发现BAK结合剂诱导蛋白质展开,暴露关键域.
结论:
- 设计的结合剂通过与BAK和BAX的直接,特定的相互作用来调节亡.
- 结合剂诱导的BAK/BAX展开是它们的作用机制的核心.
- 针对BAK和BAX的治疗策略需要和结合剂度才能有效抑制.
更多相关视频
10:58Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
17.1K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
相关概念视频
Drug-Receptor Bonds
3.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.2K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Conserved Binding Sites
4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K